- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisition The Economic Times
- Sun Pharma buys US-based Organon in $12bn all-cash deal The Times of India
- White & Case, AZB, Sullivan, Cyril Amarchand Mangaldas, Linklaters act on Sun Pharma’s $11.75 billion acquisition of Organon Bar and Bench
- Sun Pharma shares jump 7% as India’s largest drugmaker to buy U.S. firm Organon in $11.75 billion deal CNBC
- Sun Pharma’s $11.75 billion buy: Is the Organon deal valuation fair? Forbes India